(Total Views: 255)
Posted On: 11/05/2020 9:53:26 AM
Post# of 653
$RLFTF New reuters article with quote from Javitt about delay.
“A couple of weeks after the end of the fourth quarter is what we’re expecting right now,” Jonathan Javitt, founder and chief executive of NeuroRx, said, telling Reuters that the new deadline reflects challenges in running a trial in the midst of a pandemic, including keeping staff safe.
https://www.reuters.com/article/health-corona...SL8N2HR1GQ
- Pcilliterate
“A couple of weeks after the end of the fourth quarter is what we’re expecting right now,” Jonathan Javitt, founder and chief executive of NeuroRx, said, telling Reuters that the new deadline reflects challenges in running a trial in the midst of a pandemic, including keeping staff safe.
https://www.reuters.com/article/health-corona...SL8N2HR1GQ
- Pcilliterate
(0)
(0)
$MJ
